ARCHIVES

NDA For MeCCNU Turned Down By Oncologic Drugs Advisory Committee

This article is from The Cancer Letter archive.

Vol. 02 No. 36 | September 3, 1976

Download PDF Visit The Full Archive

Related Articles

IOM Finds Insufficient Evidence to Link Polio Vaccine, Cancer

October 25, 2002

Efaproxyn Improved Survival Of Patients With Brain Mets

October 29, 2004

Community Based Control Program Taking Final Shape

April 29, 1977

Cancer Program Advocates, Success Overcame Powerful Negative Factors To Win Budget Fight

August 10, 1979

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

November 28, 2014

In Brief: Zubrod “One Person Who Made The Difference” In Drug Program, DeVita Says in Center’s 25th

July 27, 1984